Efficacy and Safety of Acupuncture Combined With Chinese Herbal Fumigation for Chronic Non-Specific Neck Pain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversiti Tunku Abdul Rahman

About this trial

Chronic non-specific neck pain is a common musculoskeletal disorder that significantly affects quality of life and functional ability. Conventional treatments often provide limited relief and may be associated with adverse effects. Acupuncture and Chinese herbal fumigation are commonly used therapies in traditional Chinese medicine and have shown potential benefits in pain relief and functional recovery.

This multicenter randomized controlled trial aims to evaluate the efficacy and safety of acupuncture combined with Chinese herbal fumigation in patients with chronic non-specific neck pain. A total of 120 participants will be randomly assigned to three groups: acupuncture combined with Chinese herbal fumigation, acupuncture combined with sham fumigation, and acupuncture alone. All participants will receive five treatment sessions within three weeks, followed by a four-week follow-up period.

The primary outcome measure is pain intensity assessed using the Visual Analog Scale (VAS). Secondary outcome measures include the Neck Disability Index (NDI), cervical range of motion, Pittsburgh Sleep Quality Index (PSQI), quality of life scale, and Central Sensitization Inventory (CSI). This study aims to provide high-quality clinical evidence regarding the effectiveness of acupuncture combined with Chinese herbal fumigation for chronic non-specific neck pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 to 65 years, any gender

Diagnosed with chronic non-specific neck pain lasting ≥ 3 months

Visual Analog Scale (VAS) pain score ≥ 4

Cervical range of motion reduced by ≥ 20% compared to normal range

Disqualifiers

Presence of confirmed cervical disc herniation, nerve compression, or other specific pathologies (e.g., infection, tumor, fracture, etc.)

History of cervical spine surgery or recent acute neck trauma

Concomitant severe systemic diseases (e.g., cardiovascular, hepatic, renal, hematological, or psychiatric disorders)

Pregnancy or breastfeeding

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acupuncture

    Other intervention

    Single-use sterile acupuncture needles (0.30 × 40 mm, Huatuo brand) are inserted at bilateral cervical Jiaji points (EX-B2). Needles are retained for 20 minutes with manipulation to achieve deqi. Treatment is provided five times over three weeks (approximately twice per week).

  • Wenyang Tongluo Fumigation Formula

    Other intervention

    A proprietary Chinese herbal formula (30 g herbal powder decocted with 1000 mL water) used for local neck fumigation. Temperature is controlled at 35°C for 3 minutes, then 40°C for 30 minutes. Steam outlet positioned 30 cm from the neck. Treatment is provided five times over three weeks.

  • Sham Fumigation

    Other intervention

    Pure water (1000 mL) is heated to produce steam for local neck fumigation under identical temperature and duration conditions as the active fumigation. Treatment is provided five times over three weeks.

Treatment groups

120 Participants
are divided into 3 treatment groups
Group A: Acupuncture Combined with Chinese Herbal FumigationExperimental treatment 2 interventions
Group B: Acupuncture Combined with Sham FumigationSham comparator 2 interventions
Group C: Acupuncture AloneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain Intensity as Measured by the Visual Analog Scale

The Visual Analog Scale is a 10 cm horizontal line ranging from 0 (no pain) to 10 (worst possible pain). Participants mark their current pain level on the line, and the distance in centimeters from the "no pain" end to the mark is recorded as the pain score.

Time frame
Baseline (T0), immediately after first treatment (T1), immediately after fifth treatment (T2), and at 4-week follow-up after final treatment (T3)

Secondary outcomes

1

Neck Disability Index

A 10-item questionnaire assessing the impact of neck pain on daily living, work ability, and self-care. Each item is scored from 0 to 5, with total scores ranging from 0 to 50. Higher scores indicate greater disability.

Time frame
Baseline (T0), immediately after first treatment (T1), immediately after fifth treatment (T2), and at 4-week follow-up after final treatment (T3)
2

Cervical Range of Motion

Measured using a digital goniometer to assess cervical flexion, extension, lateral flexion, and rotation. Values are recorded in degrees. An increase of ≥20% compared to baseline is considered clinically significant functional improvement.

Time frame
Baseline (T0), after first treatment (T1), after fifth treatment (T2), and at 4-week follow-up (T3)
3

SF-36 Quality of Life Scale

A 36-item questionnaire assessing health status across eight domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better quality of life.

Time frame
Baseline (T0), after fifth treatment (T2), and at 4-week follow-up (T3)
4

Pittsburgh Sleep Quality Index

A 19-item self-rated questionnaire assessing sleep quality over the past month, including sleep duration, sleep efficiency, and sleep disturbances. Total scores range from 0 to 21, with higher scores indicating poorer sleep quality. A reduction of ≥3 points from baseline is considered clinically significant improvement.

Time frame
Baseline (T0), after fifth treatment (T2), and at 4-week follow-up (T3)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: